Showing results (1131-1140 of 1,344) with videos related to
Sort By:
Pageof 135
The Pharmacogenomics Journal|August 3, 2010
A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression dataJ Luo, M Schumacher, A Scherer, et al.The Pharmacogenomics Journal|August 3, 2010
Variability in GWAS analysis: the impact of genotype calling algorithm inconsistenciesK Miclaus, M Chierici, C Lambert, et al.The Pharmacogenomics Journal|March 7, 2012
The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophreniaS A Lott, P R Burghardt, K J Burghardt, et al.The Pharmacogenomics Journal|April 12, 2012
An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrenceT Winder, P M Wilson, D Yang, et al.The Pharmacogenomics Journal|May 2, 2012
The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN studyA C Frazier-Wood, J M Ordovas, R J Straka, et al.The Pharmacogenomics Journal|August 17, 2011
Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populationsH E Wheeler, E R Gamazon, A L Stark, et al.The Pharmacogenomics Journal|February 22, 2012
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expressionJ D Duarte, S T Turner, B Tran, et al.The Pharmacogenomics Journal|February 16, 2012
Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndromeE Radulescu, B Ganeshan, L Minati, et al.The Pharmacogenomics Journal|January 11, 2012
Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapyA Pohl, A El-Khoueiry, D Yang, et al.The Pharmacogenomics Journal|January 11, 2012
Clinical and economic challenges facing pharmacogenomicsJ Cohen, A Wilson, K ManzolilloPageof 135